SLC2A1 and cancer: In our study, based on the TCGA-GTEx pan-cancer dataset, we found that SLC2A1 is highly expressed in most cancers compared with normal tissues, which we further confirmed via the GEO datasets, protein expression data from the HPA database, and our own data.